Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingCyclophosphamideHematopoietic Stem CellsHistocompatibilityTransplantation, IsogeneicBone Marrow DiseasesCombined Modality TherapyKidney TransplantationRecurrenceHematopoiesisMice, Inbred C57BLTime FactorsTreatment OutcomeRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationRemission InductionImmunosuppressive AgentsHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsSurvival AnalysisTransplantation ImmunologyLeukemia, MyeloidRetrospective StudiesGraft vs Host ReactionImmunosuppressionLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsLymphocyte DepletionStem Cell TransplantationAcute DiseaseLeukocyte TransfusionHeart TransplantationColony-Forming Units AssayT-LymphocytesSevere Combined ImmunodeficiencySurvival RateChimeraFollow-Up StudiesHLA AntigensBreast NeoplasmsMyelodysplastic SyndromesFlow CytometryMice, Inbred BALB CLung TransplantationAntineoplastic AgentsHematologic DiseasesActuarial AnalysisCyclosporineCell ProliferationBone DensityCell DifferentiationDisease-Free SurvivalNeoplasmsLymphocyte TransfusionPrognosisNuclear FamilyCarmustineOrgan TransplantationEtoposidePancytopeniaApoptosisGraft vs Tumor EffectCytarabineLeukocyte CountGraft vs Leukemia EffectGranulocyte Colony-Stimulating FactorCell Line, TumorCells, CulturedBone NeoplasmsSpleenCytomegalovirus InfectionsAntibodies, MonoclonalMelphalanBone ResorptionLymphomaTumor Cells, Cultured